免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Evaluation of Depression and Sleep Disorders in Endometriosis Patients

Evaluation of Depression and Sleep Disorders in Endometriosis Patients

Study Description
Brief Summary:
The aim of this study was to compare the depression and sleep disturbances of operated endometriosis patients before and after the operation. The main objective here is to provide data on how patients' psychological states and sleep patterns are affected by the symptoms of endometriosis and how these effects can be corrected. In this way, it is aimed to determine whether the patients have psychological support needs and to give the planned treatment due to endometriosis in the early period. As a secondary goal, it is planned to keep the patients in follow-up with their improved sleep and psychological conditions, and to improve their adherence to treatment and quality of life.

Condition or disease Intervention/treatment
Endometriosis Sleep Depression Behavioral: Beck Depression Scale and Pittsburgh Sleep Quality Index

Study Design
Layout table for study information
Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of Depression and Sleep Disorders in Endometriosis Patients Preoperatively and Postoperatively
Actual Study Start Date : July 3, 2019
Actual Primary Completion Date : May 3, 2020
Actual Study Completion Date : May 3, 2020
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
  1. Beck Depression Scale [ Time Frame: 1 week ]

    postoperative depression in endometriosis patients will be evaluated. Consists of 21 questions scored between 0-3.

    HIGH SCORE SHOWS TO HIGH DEPRESSION. (0-63 POINTS)


  2. Pittsburgh Sleep Quality Index [ Time Frame: 1 week ]

    postoperative sleep disorders of endometriosis patients will be evaluated. Consists of 9 questions scored between 0-3.

    HIGH SCORE SHOWS BAD SLEEP QUALITY. (0-27 POINTS)



Eligibility Criteria
Contacts and Locations
Tracking Information
First Submitted Date July 3, 2019
First Posted Date July 5, 2019
Last Update Posted Date May 22, 2020
Actual Study Start Date July 3, 2019
Actual Primary Completion Date May 3, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: July 4, 2019)
  • Beck Depression Scale [ Time Frame: 1 week ]
    postoperative depression in endometriosis patients will be evaluated. Consists of 21 questions scored between 0-3. HIGH SCORE SHOWS TO HIGH DEPRESSION. (0-63 POINTS)
  • Pittsburgh Sleep Quality Index [ Time Frame: 1 week ]
    postoperative sleep disorders of endometriosis patients will be evaluated. Consists of 9 questions scored between 0-3. HIGH SCORE SHOWS BAD SLEEP QUALITY. (0-27 POINTS)
Original Primary Outcome Measures
 (submitted: July 3, 2019)
  • Beck Depression Scale [ Time Frame: 1 week ]
    postoperative depression in endometriosis patients will be evaluated
  • Pittsburgh Sleep Quality Index [ Time Frame: 1 week ]
    postoperative sleep disorders of endometriosis patients will be evaluated
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Evaluation of Depression and Sleep Disorders in Endometriosis Patients
Official Title Evaluation of Depression and Sleep Disorders in Endometriosis Patients Preoperatively and Postoperatively
Brief Summary The aim of this study was to compare the depression and sleep disturbances of operated endometriosis patients before and after the operation. The main objective here is to provide data on how patients' psychological states and sleep patterns are affected by the symptoms of endometriosis and how these effects can be corrected. In this way, it is aimed to determine whether the patients have psychological support needs and to give the planned treatment due to endometriosis in the early period. As a secondary goal, it is planned to keep the patients in follow-up with their improved sleep and psychological conditions, and to improve their adherence to treatment and quality of life.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population The study group included patients with indications for operation and who agreed to test for depression and sleep disorders.
Condition
  • Endometriosis
  • Sleep
  • Depression
Intervention Behavioral: Beck Depression Scale and Pittsburgh Sleep Quality Index
postoperative depression and sleep disorders in patients with endometriosis will be evaluated
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: July 3, 2019)
50
Original Estimated Enrollment Same as current
Actual Study Completion Date May 3, 2020
Actual Primary Completion Date May 3, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • 18-49 years of age with no known psychiatric disorder and
  • Endometriosis patients with indications for operation

Exclusion Criteria:

  • Patients receiving only medical treatment without any indication for operation,
  • those with a known psychiatric disease,
  • patients with sleep disorders due to another reason,
  • Patients over the age of 49, patients under the age of 18,
  • Patients with malignancy,
  • pregnant women
Sex/Gender
Sexes Eligible for Study: Female
Ages 18 Years to 50 Years   (Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Turkey
Removed Location Countries  
 
Administrative Information
NCT Number NCT04009902
Other Study ID Numbers 2019.03.77
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement Not Provided
Responsible Party Pınar Kadirogulları, Kanuni Sultan Suleyman Training and Research Hospital
Study Sponsor Kanuni Sultan Suleyman Training and Research Hospital
Collaborators Not Provided
Investigators Not Provided
PRS Account Kanuni Sultan Suleyman Training and Research Hospital
Verification Date May 2020